The ABCs of Clinical Trials Part 2 – What Every Rare Disease Family Should Know

This is a recording of the webinar “The ABC’s of Clinical Trials: Part 2 – What Every Rare Family Should Know,” which was held on October 21st, 2020.

Our Caregiver Voice was:
Mery Oman, mother to a child who has an SCN2A Disorder. She is also a Board member of the FamilieSCN2A Foundation.

Our panelists were:
Steven L. Roberds, PhD – Chief Scientific Officer at the TS Alliance. Steve has a PhD in Pharmacology and significant experience working on clinical trials from both the pharmaceutical and patient advocacy group perspective.

Carolyn McMicken, PhD – Director, Medical Science Liaisons at Neurocrine Biosciences. Carolyn is a neuropsychologist by training with extensive experience in clinical trials and rare epilepsy

Privacy Statement

We recognize that your privacy is important. Our privacy statement outlines the types of personal information we receive and collect when you use this website, as well as some of the steps we take to safeguard information. Please read more here.